To investigate the potential role of CD44 as a surface marker to guide the dissection of the phenotypic heterogeneity of luminal breast cancer cells, we identified those genes showing high transcriptional variability across single MCF7 cells (n = 778) and intersected them with annotation from the Cell Surface Protein Atlas36. This evidence concerns the gene CD44 and breast carcinoma.